ILMN vs MEDP
As of Sep 20, 2026, Illumina (ILMN) scores 7.4/10 and Medpace Holdings (MEDP) 6.0/10 on AlphaStocks' five-model composite, so ILMN scores higher. ILMN trades 66% above its model fair value; MEDP trades 49% above its model fair value.
ILMN
ILLUMINA, INC.
7.4
Consider Buy
$239.53
MEDP
Medpace Holdings, Inc.
6.0
Consider Buy
$612.42
ILMN vs MEDP: Which is the Better Investment?
ILLUMINA, INC. (ILMN) scores 7.4/10 while Medpace Holdings, Inc. (MEDP) scores 6.0/10 on AlphaStocks' composite model. ILLUMINA, INC. has the higher composite rating of Consider Buy. On a P/E basis, Medpace Holdings, Inc. trades at 40.1x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | ILMN | MEDP |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 7.4/10▲ | 6.0/10 |
| Rating | Consider Buy▲ | Consider Buy |
| Price | $239.53 | $612.42 |
| P/E Ratio | 44.0 | 40.1▲ |
| ROE | 10.9% | 48.9%▲ |
| Market Cap | $37B | $18B |
| Fair Value | $144.12 | $410.35 |
| Dividend Yield | — | — |
| Sector Rank | #9 of 168▲ | #51 of 168 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Attractive▲ | Neutral |
| Graham | Caution | Caution |
| Lynch | Neutral | Strong▲ |
| Greenblatt | Caution▲ | Limited Data |
Related comparisons
ILMN vs MEDP: Which Stock Scores Higher?
ILLUMINA, INC. (ILMN) and Medpace Holdings, Inc. (MEDP) are both in the Health Care sector. ILMN currently leads with a composite score of 7.4/10 (Consider Buy) compared to MEDP's 6.0/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer